[1] FORD A C,SPERBER A D,CORSETTI M,et al. Irritable bowel syndrome[J]. Lancet,2020,396(10263):1675-1688.
[2] 李彦楠,杨丽旋,赵钟辉,等. 《2020年中国肠易激综合征专家共识意见》解读[J]. 中国临床医生杂志,2021,49(10):5.
[3] SEBASTIAN D J. Irritable bowel syndrome[J]. Med Clin(Barc),2022, 158(2):76-81.
[4] 温艳东,李保双,王彦刚,等. 消化系统常见病肠易激综合征中医诊疗指南(基层医生版)[J]. 中华中医药杂志,2020,35(7):3518-3523.
[5] 付伊萌. 基于代谢组学技术探究标本配穴针灸防治腹泻型肠易激综合征的效应机制[D].湖北中医药大学,2022.
[6] 孙大娟,由新鹏,迟莉丽. 基于“土中泻木”理论论治肝郁脾虚型腹泻型肠易激综合征疗效观察及机制探讨[J]. 南京中医药大学学报,2020,36(2):4.
[7] BULUT ?覶 B,?魻ZKULA G,ISILKI S,et al. Anxiety,depression,and anger in functional gastrointestinal disorders:a cross-sectional observational study[J]. Psych Res,2018,268(10):368-372.
[8] 邹多武. 回眸40年胃肠动力疾病和功能性胃肠病相关发展[J]. 中华消化杂志,2021,41(3):4.
[9] 赵尔樱,周佳玮,褚海云,等. 肠易激综合征流行病学与致病因素研究进展[J]. 中国公共卫生,2021,37(4):5.
[10] KLEM F,WADHWA A,PROKOP L J,et al. Prevalence,risk factors,and outcomes of irritable bowel syndrome after infectious enteritis:a systematic review and meta-analysis[J]. Gastroenterology,2017,152(5):1042-1054.
[11] 汪龙德,张萍,任培培,等. 腹泻型肠易激综合征相关发病机制及治疗的研究进展[J]. 实用中医内科杂志,2022,36(1):16-19.
[12] 楼茜欣,唐梅文,唐燕,等. 腹泻型肠易激综合征中医治疗进展[J]. 辽宁中医杂志,2020(10):3.
[13] 董玉玺,王静. 中西医结合治疗肠易激综合征临床研究进展[J]. 实用中医药杂志,2022,38(7):1264-1266.
[14] BLACK C J,FORD A C. Global burden of irritable bowel syndrome:trends,predictions and risk factors[J]. Nat Rev Gastroenterol Hepatol,2020,17(8):473-486.
[15] VASANT D H,PAINE P A,BLACK C J,et al. British Society of Gastroenterology guidelines on the management of irritable bowel syndrome[J]. Gut,2021,70(7):1214-1240.
[16] PIMENTEL M. Evidence-based management of irritable bowel syndrome with diarrhea[J]. Am J Manag Care,2018,24(3 Suppl):S35-S46.
[17] 覃尚红,梁丽,周成华,等. 胃肠起搏联合认知行为疗法治疗老年腹泻型肠易激综合征患者临床疗效观察[J]. 内科,2022,17(2):213-216.
[18] HARRIS L A,BAFFY N. Modulation of the gut microbiota:a focus on treatments for irritable bowel syndrome[J]. Postgrad Med,2017, 129(8):872-888.
[19] MAMIEVA Z,POLUEKTOVA E,SVISTUSHKIN V,et al. Antibiotics,gut microbiota,and irritable bowel syndrome:what are the relations?[J]. World J Gastroenterol,2022,28(12):1204-1219.
[20] PIMENTEL M,LEMBO A. Microbiome and its role in irritable bowel syndrome[J]. Dig Dis Sci,2020,65(3):829-839.
[21] BONETTO S,FAGOONEE S,BATTAGLIA E,et al. Recent advances in the treatment of irritable bowel syndrome[J]. Pol Arch Intern Med,2021,131(7-8):709-715.
[22] PAULA H,GROVER M,HALDER S L,et al. Non-enteric infections,antibiotic use,and risk of development of functional gastrointestinal disorders[J]. Neurogastroenterol Motil,2015,27(11):1580-1586.
[23] KROGSGAARD L R,EENSBRO A L,BYTZER P. Antibiotics:a risk factor for irritable bowel syndrome in a population-based cohort[J]. Scand J Gastroenterol,2018,53(9):1027-1030.
[24] 徐志伟,吴皓萌,敖海清,等. 肠易激综合征的舌象研究[J]. 中华中医药杂志,2014,29(10):4.
[25] 张开波,李鲜,张璐鹏,等. 腹泻型肠易激综合征的中西医研究现状[J]. 中国中西医结合消化杂志,2021,29(4):298-302.
[1]文帅永,安雨,邸莹,等.高甘油三酯血症性胰腺炎临床特征及重症化预测模型的建立[J].天津医科大学学报,2024,30(04):356.[doi:10.20135/j.issn.1006-8147.2024.04.0356]
WEN Shuaiyong,AN Yu,DI Ying,et al.Clinical features of hypertriglyceridemic acute pancreatitis and establish of a clinical prediction model for severity[J].Journal of Tianjin Medical University,2024,30(05):356.[doi:10.20135/j.issn.1006-8147.2024.04.0356]
[2]李艳,刘大军,房信响,等.心力衰竭患者抑郁风险预测模型的构建与验证[J].天津医科大学学报,2024,30(05):434.[doi:10.20135/j.issn.1006-8147.2024.05.0434]
LI Yan,LIU Dajun,FANG Xinxiang,et al.Construction and validation of a predictive model for depression risk in heart failure patients[J].Journal of Tianjin Medical University,2024,30(05):434.[doi:10.20135/j.issn.1006-8147.2024.05.0434]